BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30425103)

  • 21. Preoperative Management of Cardiovascular Medications: A Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement.
    Sahai SK; Balonov K; Bentov N; Bierle DMM; Browning LM; Cummings KC; Dougan BM; Maxwell M; Merli GJ; Oprea AD; Sweitzer B; Mauck KF; Urman RD
    Mayo Clin Proc; 2022 Sep; 97(9):1734-1751. PubMed ID: 36058586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypertension therapies compared. Are the new nevertheless better than the old?].
    MMW Fortschr Med; 2005 Mar; 147(12):6, 8. PubMed ID: 15832780
    [No Abstract]   [Full Text] [Related]  

  • 23. Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network.
    Smith SM; Winterstein AG; Gurka MJ; Walsh MG; Keshwani S; Libby AM; Hogan WR; Pepine CJ; Cooper-DeHoff RM
    J Am Heart Assoc; 2023 Jan; 12(1):e026652. PubMed ID: 36565195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
    Ku E; McCulloch CE; Vittinghoff E; Lin F; Johansen KL
    J Am Heart Assoc; 2018 Oct; 7(19):e009992. PubMed ID: 30371331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.
    Nazarzadeh M; Bidel Z; Canoy D; Copland E; Wamil M; Majert J; Smith Byrne K; Sundström J; Teo K; Davis BR; Chalmers J; Pepine CJ; Dehghan A; Bennett DA; Smith GD; Rahimi K;
    Lancet; 2021 Nov; 398(10313):1803-1810. PubMed ID: 34774144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive medications.
    Slagle MA
    South Med J; 2001 Nov; 94(11):1071-3. PubMed ID: 11780676
    [No Abstract]   [Full Text] [Related]  

  • 27. Development and trends in the drug treatment of essential hypertension.
    van Zwieten PA
    J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 'Birmingham Hypertension Square' for the optimum choice of add-in drugs in the management of resistant hypertension.
    Lip GY; Beevers M; Beevers DG
    J Hum Hypertens; 1998 Nov; 12(11):761-3. PubMed ID: 9844947
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
    Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The return on INVEST.
    Alderman MH
    JAMA; 2003 Dec; 290(21):2859-61. PubMed ID: 14657071
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacologic Issues in treating hypertension in CKD.
    Sica DA
    Adv Chronic Kidney Dis; 2011 Jan; 18(1):42-7. PubMed ID: 21224029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating hypertension in Black patients.
    Gardner NJ
    JAAPA; 2022 Feb; 35(2):15-18. PubMed ID: 35076435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High blood pressure: treatment guidelines. How you can silence the "silent killer".
    Harv Mens Health Watch; 2004 Jan; 8(6):1-4, 6-7. PubMed ID: 14734272
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the phamacologic treatment of hypertension in the Department of Veterans Affairs 1997-1999: decreased use of calcium antagonists and increased use of beta-blockers and thiazide diuretics.
    Siegel D; Lopez J; Meier J; Cunningham F
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):957-62. PubMed ID: 11587164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thiazide diuretics: first-line therapy for hypertension.
    Ramsay LE; Yeo WW; Jackson PR
    J Hypertens Suppl; 1992 Jun; 10(3):S29-32; discussion S32-3. PubMed ID: 1353112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?
    Wright JM; Lee CH; Chambers GK
    CMAJ; 1999 Jul; 161(1):25-32. PubMed ID: 10420860
    [No Abstract]   [Full Text] [Related]  

  • 38. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin converting enzyme inhibition in clinical practice. A re-examination of stepped-care: a retrospective and a prospective.
    Zanchetti A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S126-31. PubMed ID: 2580166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Are the newer antihypertensive agents better and more effective than diuretics?].
    Landmark K
    Tidsskr Nor Laegeforen; 2001 Feb; 121(6):701-5. PubMed ID: 11293353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.